A Phase 2 Study of EZN-2208 in Patients With Metastatic Breast Cancer
Public ClinicalTrials.gov record NCT01036113. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Open-Label Study of EZN-2208 (PEG-SN38) in Patients With Previously Treated Metastatic Breast Cancer (MBC)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a Phase 2, multicenter, open-label, noncomparative study to evaluate safety,efficacy and of single-agent EZN 2208 administered in patients with previously treated MBC. After discontinuation of study treatment, patients will receive care as considered appropriate by the investigator. Patients will continue to be followed for disease progression, subsequent anticancer therapy, and survival.
Study identification
- NCT ID
- NCT01036113
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 160 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 2009 (Type not available)
- Primary completion
- Feb 2012 (Actual)
- Completion
- Dec 2012 (Actual)
- Last update posted
- Feb 14, 2022
2009 – 2012
United States locations
- U.S. sites
- 36
- U.S. states
- 16
- U.S. cities
- 33
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Location #12 | Sedona | Arizona | 86336 | — |
| Location #5 | Tucson | Arizona | 85704 | — |
| Location #32 | Murrieta | California | 92562 | — |
| Location #39 | Oxnard | California | 93030 | — |
| Location #18 | Denver | Colorado | 80220 | — |
| Location #36 | New Port Richey | Florida | 34655 | — |
| Location #1 | Ocoee | Florida | 34761 | — |
| Location #40 | Niles | Illinois | 60714 | — |
| Location #15 | Carmel | Indiana | 46032 | — |
| Location #10 | Minneapolis | Minnesota | 55404 | — |
| Location #16 | Columbia | Missouri | 65201 | — |
| Location #14 | Kansas City | Missouri | 64131 | — |
| Location #2 | Henderson | Nevada | 89074 | — |
| Location#19 | Troy | New York | 12180 | — |
| Location #4 | Raleigh | North Carolina | 27607 | — |
| Location #41 | Columbus | Ohio | 43219 | — |
| Location #27 | Portland | Oregon | 97213-2996 | — |
| Location #8 | Greenville | South Carolina | 29605 | — |
| Location #33 | Abilene | Texas | 79606 | — |
| Location #34 | Arlington | Texas | 76014 | — |
| Location #9 | Austin | Texas | 78705 | — |
| Location #3 | Bedford | Texas | 76022 | — |
| Location #26 | Dallas | Texas | 75230-2510 | — |
| Location #13 | Dallas | Texas | 75231 | — |
| Location #30 | Dallas | Texas | 75237 | — |
| Location #17 | Dallas | Texas | 75246 | — |
| Location #24 | Fort Worth | Texas | 76104 | — |
| Location #11 | Houston | Texas | 77024 | — |
| Location #38 | Lewisville | Texas | 75067 | — |
| Location #31 | McAllen | Texas | 78503 | — |
| Location # 28 | Midland | Texas | 79701 | — |
| Location #35 | Sugar Land | Texas | 77479 | — |
| Location# 20 | Tyler | Texas | 75702 | — |
| Location #23 | Fairfax | Virginia | 22031 | — |
| Location #7 | Norfolk | Virginia | 23502 | — |
| Location #21 | Salem | Virginia | 24153 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01036113, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 14, 2022 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01036113 live on ClinicalTrials.gov.